Hannah Pendergraff, Ph.D., is an accomplished professional in the biotechnology field, currently serving as a Project Leader at Evotec since July 2023. Prior to this role, Hannah held the position of Principal Scientist at MiNA Therapeutics from December 2021 to July 2023. Hannah's extensive experience includes a tenure as Group Lead for Exosome Payloads, Senior Scientist, and Research Scientist at Evox Therapeutics Ltd from December 2017 to November 2021. Earlier, Hannah contributed as a Postdoctoral Researcher at the Roche Innovation Center of Copenhagen and completed a Ph.D. at the University of Southampton from 2012 to 2015. Additionally, Hannah's educational background includes a Bachelor of Science in Biology from the University of Central Arkansas. Career beginnings were with Charles River Laboratories as a Formulations Technician and at UT Southwestern Medical Center as a Research Assistant II.
This person is not in the org chart
This person is not in any teams
This person is not in any offices